Last updated on August 2020

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia

Brief description of study

This is a study of the safety and efficacy of ceftobiprole in pediatric patients with hospital-acquired bacterial pneumonia (HAP) or community-acquired bacterial pneumonia (CAP) requiring hospitalization.

Detailed Study Description

This is a randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephalosporin treatment with or without vancomycin in pediatric patients aged from 3 months to less than 18 years with HAP or CAP requiring hospitalization.

Clinical Study Identifier: NCT03439124

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.